Operaciones BioLife Solutions, Inc. - BLFS CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.07 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
BioLife Solutions Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Cierre previo* | 14.63 |
Abrir* | 14.33 |
Cambio de 1 año* | -1.31% |
Rango del día* | 14.33 - 14.67 |
Rango de 52 semanas | 12.60-26.96 |
Volumen medio (10 días) | 336.91K |
Volumen medio (3 meses) | 6.45M |
Capitalización de mercado | 977.77M |
Ratio P/E | -100.00K |
Acciones en circulación | 43.46M |
Ingresos | 163.24M |
EPS | -3.43 |
Dividendo (Rendimiento %) | N/A |
Beta | 1.78 |
Próxima fecha de resultados | Aug 7, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Jun 29, 2022 | 14.53 | 0.15 | 1.04% | 14.38 | 14.69 | 14.23 |
Jun 28, 2022 | 14.63 | -0.35 | -2.34% | 14.98 | 15.46 | 14.42 |
Jun 27, 2022 | 14.88 | -0.81 | -5.16% | 15.69 | 15.75 | 14.38 |
Jun 24, 2022 | 15.68 | 0.08 | 0.51% | 15.60 | 16.45 | 15.49 |
Jun 23, 2022 | 15.67 | 1.26 | 8.74% | 14.41 | 15.72 | 14.41 |
Jun 22, 2022 | 14.45 | 1.06 | 7.92% | 13.39 | 14.81 | 13.39 |
Jun 21, 2022 | 13.80 | -0.14 | -1.00% | 13.94 | 14.63 | 13.76 |
Jun 17, 2022 | 13.74 | 0.39 | 2.92% | 13.35 | 14.30 | 13.24 |
Jun 16, 2022 | 13.24 | -0.11 | -0.82% | 13.35 | 13.66 | 13.07 |
Jun 15, 2022 | 14.08 | 1.10 | 8.47% | 12.98 | 14.23 | 12.97 |
Jun 14, 2022 | 12.95 | -0.17 | -1.30% | 13.12 | 13.19 | 12.57 |
Jun 13, 2022 | 13.07 | -0.17 | -1.28% | 13.24 | 13.66 | 13.01 |
Jun 10, 2022 | 14.07 | 0.13 | 0.93% | 13.94 | 14.24 | 13.78 |
Jun 9, 2022 | 14.37 | 0.39 | 2.79% | 13.98 | 14.52 | 13.98 |
Jun 8, 2022 | 14.45 | -0.03 | -0.21% | 14.48 | 15.15 | 14.30 |
Jun 7, 2022 | 14.69 | 1.21 | 8.98% | 13.48 | 14.72 | 13.48 |
Jun 6, 2022 | 13.90 | 0.17 | 1.24% | 13.73 | 14.40 | 13.57 |
Jun 3, 2022 | 13.73 | -0.24 | -1.72% | 13.97 | 14.02 | 13.48 |
Jun 2, 2022 | 14.14 | 1.01 | 7.69% | 13.13 | 14.36 | 13.13 |
Jun 1, 2022 | 13.32 | -0.44 | -3.20% | 13.76 | 14.16 | 13.32 |
BioLife Solutions, Inc. Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
Monday, August 7, 2023 | ||
Hora (UTC) (UTC) 20:00 | País US
| Evento Q2 2023 BioLife Solutions Inc Earnings Release Q2 2023 BioLife Solutions Inc Earnings ReleaseForecast -Previous - |
Tuesday, November 7, 2023 | ||
Hora (UTC) (UTC) 10:59 | País US
| Evento Q3 2023 BioLife Solutions Inc Earnings Release Q3 2023 BioLife Solutions Inc Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos totales | 161.759 | 119.156 | 48.087 | 27.371 | 19.742 |
Ingresos | 161.759 | 119.156 | 48.087 | 27.371 | 19.742 |
Coste de los ingresos, total | 107.937 | 82.108 | 20.646 | 8.76 | 6.217 |
Beneficio bruto | 53.822 | 37.048 | 27.441 | 18.611 | 13.525 |
Gastos totales de explotación | 307.3 | 147.865 | 54.328 | 17.483 | 16.08 |
Gastos de venta/general/administración Gastos, total | 69.24 | 47.674 | 21.686 | 13.594 | 8.565 |
Investigación y desarrollo | 14.798 | 11.821 | 6.72 | 3.168 | 1.298 |
Ingresos de explotación | -145.541 | -28.709 | -6.241 | 9.888 | 3.662 |
Ingresos por intereses (gastos), netos No operativos | 0.01 | -0.485 | 1.359 | -0.238 | -0.396 |
Gain (Loss) on Sale of Assets | |||||
Otros, netos | 0.704 | 0.168 | 3.601 | -12.848 | -28.271 |
Ingresos netos antes de impuestos | -144.827 | -29.026 | -1.281 | -3.198 | -25.005 |
Ingresos netos después de impuestos | -139.805 | -8.908 | 1.983 | -1.657 | -25.005 |
Intereses menores | |||||
Beneficio neto antes de partidas extra. Elementos | -139.805 | -8.908 | 1.983 | -1.657 | -25.005 |
Ingresos netos | -139.805 | -8.908 | 1.983 | -1.657 | -25.005 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -139.805 | -8.908 | 1.822 | -1.657 | -25.344 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -139.805 | -8.908 | 1.822 | -1.657 | -25.344 |
Beneficio neto diluido | -139.805 | -8.908 | 1.822 | -1.657 | -25.344 |
Promedio ponderado de acciones diluidas | 42.481 | 38.5039 | 27.3063 | 19.4603 | 16.2565 |
BPA diluido sin partidas extraordinarias | -3.291 | -0.23135 | 0.06672 | -0.08515 | -1.55901 |
BPA normalizado diluido | -1.5916 | -0.31508 | 0.08696 | -0.39137 | -1.55901 |
Total Adjustments to Net Income | 0 | 0 | -0.161 | 0 | -0.339 |
Depreciation / Amortization | 9.697 | 8.202 | 3.033 | 1.079 | 0 |
Gastos (ingresos) extraordinarios | 110.382 | -4.815 | 0.668 | -9.168 | 0 |
Other Operating Expenses, Total | -4.754 | 2.875 | 1.575 | 0.05 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Ingresos totales | 37.703 | 44.259 | 40.747 | 40.533 | 36.22 |
Ingresos | 37.703 | 44.259 | 40.747 | 40.533 | 36.22 |
Coste de los ingresos, total | 23.664 | 30.288 | 27.009 | 26.194 | 24.446 |
Beneficio bruto | 14.039 | 13.971 | 13.738 | 14.339 | 11.774 |
Gastos totales de explotación | 51.308 | 94.5 | 52.152 | 116.795 | 44.187 |
Gastos de venta/general/administración Gastos, total | 21.313 | 19.529 | 16.858 | 16.766 | 16.421 |
Investigación y desarrollo | 4.152 | 4.164 | 3.425 | 3.428 | 3.781 |
Depreciation / Amortization | 1.459 | 1.461 | 2.513 | 2.863 | 2.863 |
Gastos (ingresos) extraordinarios | 0 | 40.464 | 0.001 | 69.905 | 0.011 |
Other Operating Expenses, Total | 0.72 | -1.406 | 2.346 | -2.361 | -3.335 |
Ingresos de explotación | -13.605 | -50.241 | -11.405 | -76.262 | -7.967 |
Ingresos por intereses (gastos), netos No operativos | -0.411 | -0.506 | 0.707 | -0.009 | -0.184 |
Otros, netos | 0.394 | 0.434 | 0.142 | -0.022 | 0.131 |
Ingresos netos antes de impuestos | -13.622 | -50.313 | -10.556 | -76.293 | -8.02 |
Ingresos netos después de impuestos | -13.714 | -50.228 | -9.957 | -72.554 | -7.421 |
Beneficio neto antes de partidas extra. Elementos | -13.714 | -50.228 | -9.957 | -72.554 | -7.421 |
Ingresos netos | -13.714 | -50.228 | -9.957 | -72.554 | -7.421 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -13.714 | -50.228 | -9.957 | -72.554 | -7.421 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -13.714 | -50.228 | -9.957 | -72.554 | -7.421 |
Beneficio neto diluido | -13.714 | -50.228 | -9.957 | -72.554 | -7.421 |
Promedio ponderado de acciones diluidas | 43.0276 | 42.7949 | 42.648 | 42.4602 | 42.0141 |
BPA diluido sin partidas extraordinarias | -0.31873 | -1.17369 | -0.23347 | -1.70875 | -0.17663 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | -0.31873 | -0.55909 | -0.23345 | -0.63862 | -0.17646 |
Total Adjustments to Net Income | 0 | 0 | 0 | ||
Ajuste por dilución |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Activo Corriente | 138.452 | 126.088 | 114.712 | 24.113 | 37.564 |
Efectivo e inversiones a corto plazo | 19.442 | 69.86 | 90.403 | 6.448 | 30.657 |
Efectivo y Equivalentes | 19.442 | 69.86 | 90.403 | 6.448 | 30.657 |
Inversiones a corto plazo | |||||
Total deudores, neto | 33.936 | 23.217 | 8.006 | 5.345 | 3.045 |
Accounts Receivable - Trade, Net | 33.936 | 23.217 | 8.006 | 5.345 | 3.045 |
Total Inventory | 34.904 | 28.345 | 11.602 | 10.972 | 3.509 |
Prepaid Expenses | 6.879 | 4.656 | 4.648 | 1.348 | 0.353 |
Total Assets | 450.229 | 554.286 | 234.829 | 92.816 | 45.467 |
Property/Plant/Equipment, Total - Net | 48.266 | 46.611 | 24.517 | 10.534 | 1.319 |
Property/Plant/Equipment, Total - Gross | 62.389 | 55.624 | 28.77 | 13.229 | 3.647 |
Accumulated Depreciation, Total | -14.123 | -9.013 | -4.253 | -2.695 | -2.328 |
Intangibles, Net | 32.088 | 152.149 | 31.049 | 21.982 | 0 |
Long Term Investments | 5.069 | 4.372 | 5.872 | 2.5 | 6.548 |
Other Long Term Assets, Total | 1.613 | 0.325 | 0.23 | 0.05 | 0.036 |
Total Current Liabilities | 44.582 | 42.7 | 15.573 | 7.669 | 1.939 |
Accounts Payable | 15.367 | 14.945 | 3.672 | 3.119 | 0.72 |
Accrued Expenses | 16.245 | 11.405 | 4.931 | 4.173 | 1.089 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 10.998 | 15.339 | 6.348 | 0.377 | 0.13 |
Total Liabilities | 86.041 | 76.239 | 29.583 | 49.362 | 30.835 |
Total Long Term Debt | 23.919 | 6.644 | 0.667 | 0 | 0 |
Long Term Debt | 23.793 | 6.353 | 0.655 | ||
Minority Interest | |||||
Other Liabilities, Total | 17.29 | 21.408 | 13.343 | 41.693 | 28.896 |
Total Equity | 364.188 | 478.047 | 205.246 | 43.454 | 14.632 |
Common Stock | 0.043 | 0.042 | 0.033 | 0.021 | 0.019 |
Additional Paid-In Capital | 611.739 | 585.397 | 302.598 | 143.485 | 113.008 |
Retained Earnings (Accumulated Deficit) | -246.915 | -107.11 | -97.385 | -100.052 | -98.395 |
Other Equity, Total | -0.679 | -0.282 | |||
Total Liabilities & Shareholders’ Equity | 450.229 | 554.286 | 234.829 | 92.816 | 45.467 |
Total Common Shares Outstanding | 42.8322 | 41.8175 | 33.0392 | 20.8255 | 18.5474 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
Goodwill, Net | 224.741 | 224.741 | 58.449 | 33.637 | 0 |
Other Current Assets, Total | 43.291 | 0.01 | 0.053 | ||
Current Port. of LT Debt/Capital Leases | 1.972 | 1.011 | 0.622 | ||
Capital Lease Obligations | 0.126 | 0.291 | 0.012 | ||
Deferred Income Tax | 0.25 | 5.487 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 132.789 | 138.452 | 135.874 | 118.057 | 118.701 |
Efectivo e inversiones a corto plazo | 19.105 | 19.442 | 27.036 | 24.001 | 59.463 |
Efectivo y Equivalentes | 19.105 | 19.442 | 27.036 | 24.001 | 59.463 |
Total deudores, neto | 30.343 | 33.936 | 32.436 | 31.257 | 24.271 |
Accounts Receivable - Trade, Net | 30.343 | 33.936 | 32.436 | 31.257 | 24.271 |
Total Inventory | 41.329 | 34.904 | 33.747 | 33.335 | 30.2 |
Prepaid Expenses | 6.201 | 6.879 | 8.041 | 6.89 | 4.757 |
Other Current Assets, Total | 35.811 | 43.291 | 34.614 | 22.574 | 0.01 |
Total Assets | 446.47 | 450.229 | 487.679 | 470.379 | 544.012 |
Property/Plant/Equipment, Total - Net | 50.939 | 48.266 | 47.236 | 45.873 | 46.647 |
Property/Plant/Equipment, Total - Gross | 66.013 | 62.389 | 60.495 | 57.457 | 56.851 |
Accumulated Depreciation, Total | -15.074 | -14.123 | -13.259 | -11.584 | -10.204 |
Goodwill, Net | 224.741 | 224.741 | 224.741 | 224.741 | 224.741 |
Intangibles, Net | 30.629 | 32.088 | 74.013 | 76.524 | 149.286 |
Long Term Investments | 5.069 | 5.069 | 5.069 | 4.372 | 4.372 |
Other Long Term Assets, Total | 2.303 | 1.613 | 0.746 | 0.812 | 0.265 |
Total Current Liabilities | 47.319 | 44.582 | 36.948 | 33.298 | 35.04 |
Accounts Payable | 15.525 | 15.367 | 13.14 | 11.537 | 11.711 |
Accrued Expenses | 17.77 | 16.245 | 10.118 | 9.489 | 8.866 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.411 | 1.972 | 2.223 | 1.516 | 0.708 |
Other Current Liabilities, Total | 12.613 | 10.998 | 11.467 | 10.756 | 13.755 |
Total Liabilities | 88.363 | 86.041 | 79.43 | 58.066 | 65.492 |
Total Long Term Debt | 23.787 | 23.919 | 24.373 | 6.401 | 6.566 |
Long Term Debt | 23.692 | 23.793 | 24.207 | 6.188 | 6.313 |
Capital Lease Obligations | 0.095 | 0.126 | 0.166 | 0.213 | 0.253 |
Other Liabilities, Total | 16.994 | 17.29 | 17.72 | 17.218 | 18.998 |
Total Equity | 358.107 | 364.188 | 408.249 | 412.313 | 478.52 |
Common Stock | 0.043 | 0.043 | 0.043 | 0.043 | 0.042 |
Additional Paid-In Capital | 619.227 | 611.739 | 604.06 | 597.81 | 591.002 |
Retained Earnings (Accumulated Deficit) | -260.629 | -246.915 | -194.597 | -184.64 | -112.086 |
Total Liabilities & Shareholders’ Equity | 446.47 | 450.229 | 487.679 | 470.379 | 544.012 |
Total Common Shares Outstanding | 43.29 | 42.8322 | 42.706 | 42.5367 | 42.3311 |
Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
Deferred Income Tax | 0.263 | 0.25 | 0.389 | 1.149 | 4.888 |
Other Equity, Total | -0.534 | -0.679 | -1.257 | -0.9 | -0.438 |
Preferred Stock - Non Redeemable, Net | 0 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | -139.805 | -8.908 | 1.983 | -1.657 | 3.266 |
Efectivo de actividades de explotación | -8.488 | -4.593 | 6.645 | 1.213 | 2.348 |
Efectivo de actividades de explotación | 6.775 | 4.663 | 2.035 | 0.718 | 0.338 |
Partidas no monetarias | 134.988 | 13.835 | 3.988 | 7.086 | 2.064 |
Cambios en el capital circulante | -14.905 | -2.258 | -1.097 | -4.472 | -3.32 |
Efectivo de actividades de inversión | -58.117 | -13.192 | -24.715 | -27.018 | -6.5 |
Gastos de capital | -13.921 | -14.756 | -7.808 | -2.33 | -0.5 |
Otras partidas de flujo de caja de inversión, total | -44.196 | 1.564 | -16.907 | -24.688 | -6 |
Efectivo procedente de actividades de financiación | 16.316 | -2.778 | 102.078 | 1.596 | 28.146 |
Elementos de flujo de caja de financiación | -1.843 | -1.302 | -0.499 | 0.415 | 15.707 |
Emisión (retiro) de acciones, neto | 0.323 | 1.418 | 101.593 | 1.181 | 12.9 |
Emisión (amortización) de deuda, neta | 17.836 | -2.894 | 0.984 | -0.025 | |
Variación neta de la tesorería | -50.397 | -20.586 | 84.008 | -24.209 | 23.994 |
Total Cash Dividends Paid | 0 | -0.436 | |||
Amortization | 9.697 | 8.202 | 3.033 | 1.079 | |
Deferred Taxes | -5.238 | -20.127 | -3.297 | -1.541 | |
Efectos del cambio de divisas | -0.108 | -0.023 | 0 | ||
Intereses pagados en efectivo | 0.586 | 0.452 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -13.714 | -139.805 | -89.577 | -79.62 | -7.066 |
Cash From Operating Activities | -2.712 | -8.488 | -16.345 | -17.841 | -7.924 |
Cash From Operating Activities | 1.721 | 6.775 | 5.056 | 3.257 | 1.653 |
Amortization | 1.459 | 9.697 | 8.236 | 5.725 | 2.863 |
Non-Cash Items | 8.36 | 134.988 | 85.276 | 76.856 | 2.493 |
Changes in Working Capital | -0.551 | -14.905 | -20.399 | -19.721 | -7.268 |
Cash From Investing Activities | 2.926 | -58.117 | -43.223 | -27.34 | -2.27 |
Capital Expenditures | -4.296 | -13.921 | -8.206 | -4.265 | -2.27 |
Other Investing Cash Flow Items, Total | 7.222 | -44.196 | -35.017 | -23.075 | 0 |
Cash From Financing Activities | -0.562 | 16.316 | 16.941 | -0.47 | -0.181 |
Financing Cash Flow Items | -0.56 | -1.843 | -1.246 | -0.524 | -0.313 |
Issuance (Retirement) of Stock, Net | 0.125 | 0.323 | 0.307 | 0.301 | 0.257 |
Issuance (Retirement) of Debt, Net | -0.127 | 17.836 | 17.88 | -0.247 | -0.125 |
Net Change in Cash | -0.337 | -50.397 | -42.803 | -45.841 | -10.397 |
Deferred Taxes | 0.013 | -5.238 | -4.937 | -4.338 | -0.599 |
Foreign Exchange Effects | 0.011 | -0.108 | -0.176 | -0.19 | -0.022 |
Cash Interest Paid | 0.497 | 0.586 | 0.23 | 0.121 | 0.091 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Casdin Capital, LLC | Hedge Fund | 17.5959 | 7646508 | 74973 | 2023-05-22 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 11.4884 | 4992424 | -63094 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 5.7164 | 2484155 | 23415 | 2023-03-31 | LOW |
WAVI Holding AG | Corporation | 4.5545 | 1979226 | 0 | 2021-10-26 | |
Fred Alger Management, LLC | Investment Advisor/Hedge Fund | 4.4302 | 1925215 | -52704 | 2023-03-31 | MED |
Geneva Capital Management LLC | Investment Advisor | 3.5868 | 1558693 | 38640 | 2023-03-31 | LOW |
Park West Asset Management LLC | Hedge Fund | 3.3439 | 1453129 | 502143 | 2023-03-31 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.5226 | 1096227 | 38886 | 2023-03-31 | LOW |
Palisade Capital Management, LLC | Investment Advisor/Hedge Fund | 2.4848 | 1079814 | 50191 | 2023-03-31 | LOW |
Jennison Associates LLC | Investment Advisor/Hedge Fund | 2.1295 | 925381 | -67858 | 2023-03-31 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 2.1223 | 922290 | -161464 | 2023-03-31 | LOW |
Granahan Investment Management, Inc. | Investment Advisor | 1.9587 | 851197 | 5416 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.531 | 665316 | 17849 | 2023-03-31 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 1.5192 | 660208 | 14147 | 2023-03-31 | LOW |
Gagnon Securities LLC | Investment Advisor/Hedge Fund | 1.4956 | 649918 | 88856 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.1236 | 488275 | 216856 | 2023-03-31 | LOW |
Millennium Management LLC | Hedge Fund | 1.1032 | 479406 | -190796 | 2023-03-31 | HIGH |
British Columbia Investment Management Corp. | Pension Fund | 0.9205 | 400000 | 107551 | 2023-03-31 | LOW |
Peregrine Capital Management, LLC | Investment Advisor | 0.8419 | 365874 | 80226 | 2023-03-31 | LOW |
New York State Common Retirement Fund | Pension Fund | 0.8341 | 362462 | 8996 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group530K+
Traders
87K+
Clientes activos mensualmente
$46M+
Volumen mensual de inversión
$31M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
BioLife Solutions, Inc. Company profile
Sobre BioLife Solutions Inc
BioLife Solutions, Inc. se dedica a desarrollar, fabricar y comercializar herramientas y servicios de bioproducción para la industria de la terapia celular y génica (CGT). Sus productos se utilizan en la investigación básica y aplicada y en la fabricación comercial de terapias biológicas. Los clientes utilizan sus productos para mantener la salud y la función del material biológico durante el abastecimiento, la fabricación, el almacenamiento y la distribución de células y tejidos. Cuenta con una cartera de herramientas y servicios que se centran en la biopreservación, el almacenamiento congelado y la descongelación de materiales biológicos. Su oferta de productos en el ámbito de las herramientas y servicios de bioproducción incluye medios de bioconservación, dispositivos de descongelación automatizados, contenedores de envío inteligentes conectados a la nube, tecnología de congelación y almacenamiento y componentes relacionados, y almacenamiento de material biológico y farmacéutico. Sus productos de medios de bioconservación son HypoThermosol FRS y CryoStor. Su línea de productos Astero ThawSTAR incluye productos automatizados de descongelación de viales y criobolsas.
El precio actual de la acción BioLife Solutions, Inc. en tiempo real es 14.52 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Henkel AG & Co KGaA, Yandex N.V., Cathay, Annexon, Inc., ICF International y ProShares Ultra S&P500. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
Suite 310
3303 Monte Villa Parkway
BOTHELL
WASHINGTON 98021
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 530.000 traders de todo el mundo que eligen operar con Capital.com